Peptide Distributor Qualification Checklist (Wholesale B2B)

Distributors need a manufacturer partner who can ship honest MOQ tiers, lot-linked documents that survive customer QA, and bulk paths without dragging a gray retail assortment into your catalog. This article is the full qualification path for wholesale and export distributors evaluating Peptisova.

It is not a consumer vial-mall shopping guide, not clinic-dispense merchandising, and not personal-use advice. Scenario hub: Distributors.

---

Who this checklist is for

If your business model is Melanotan / performance mall retail or consumer dosing content, we are the wrong partner (Compliance).

---

Buyer pain points this path solves

• Need honest MOQ / volume tiers—not every SKU “contact for price.”
• Require lot COAs + packing lists that survive customer QA.
• Want a bulk lyophilized API path without gray retail assortments.
• Need reorder continuity (batch numbers) across shipments.
• Must diligence ownership so you are not underwriting a silent reseller layer.

---

Dual-track commerce: catalog vs bulk / OEM

Peptisova separates:

Start on catalog when you need speed and declared MOQs (MOQ & trial kits). Move to Bulk peptide API when vial economics break. Scope branded kits only when packaging control is real (OEM private label).

Format choice: Lyophilized vials vs powder API.

---

Documentation / ops checklist

1. Dual-track clarity — know which SKUs are Track A vs Track B (Products, Bulk peptide API).
2. Lot COA per shipment — not only a vault sample (COA Vault; What a COA proves).
3. HPLC/MS process honesty (Quality; HPLC/MS checklist).
4. Retain batch IDs across reorders (batch numbers guide).
5. Partner diligence (verify hub; Company Fact Sheet; manufacturer vs reseller).
6. Cert-language hygiene — PDFs over badge walls (GMP-ready language).
7. Destination docs listed on RFQ when customers or import require them (RFQ fields).

Expanding packets: COA vs full QA packet.

---

Buyer decision framework (distributor week-one)

1. Map your assortment needs to allowed Peptisova categories—exclude Melanotan/performance mall SKUs up front.
2. Score Peptisova against two alternatives on the same columns (alternatives checklist).
3. Pull sample COA shapes from the COA Vault.
4. Place a Track A trial on a trust SKU (many distributors start with lines like Glutathione 100 mg or cosmetic catalog APIs).
5. File lot IDs before the second PO.
6. Open bulk/OEM RFQs only after documentation habits are proven.

---

Related catalog SKUs distributors often qualify

• L-Glutathione (Reduced) 100 mg · buyer guide
• GHK-Cu 10 mg · buyer guide
• Somatostatin-14 and other research/industrial catalog lines via Products
• Bulk RFQ → Bulk peptide API

Always confirm soft-band MOQ/purity on the live PDP—blog text is not a quote.

---

QC questions distributors should ask in writing

• Who signs the lot COA and investigates OOS for catalog families we will resell?
• Will every shipment include production lot COAs and packing lists with matching IDs?
• How are volume tiers communicated—PDP badges, sales sheets, or RFQ only?
• Can kg-scale powder be quoted on the bulk path without forcing a retail assortment?
• Payment and commercial rails: B2B contract/T/T style vs crypto-discount retail theater?
• Explicit confirmation: no Melanotan wholesale through this partnership?

---

Deeper scenario notes for wholesale teams

Distributors often serve mixed customers: some want cosmetic catalog APIs with tidy MOQs; others want research/industrial lines with stricter method language. Keep those conversations in separate RFQ threads when documentation requirements diverge. A single “send everything” email is how packing lists and COA expectations get blurred.

When you resell, your customer QA inherits your documentation habits. If you only file vault samples, your customer will eventually ask for the ship-lot file and you will not have it. Build the boring tracker early (batch numbers).

Commercial honesty also includes saying no. If a downstream retailer asks you to add Melanotan because “everyone sells it,” that request is a compliance veto for a Peptisova partnership—not a negotiation item (Compliance). Protecting assortment integrity protects your other SKUs’ diligence story.

For China-based manufacturing diligence specifically, fold ownership and cert questions into the Western-buyer interview script (China partner questions). Price only after vetoes and document samples clear.

---

What this page is NOT

This checklist is not:

• Melanotan or performance-mall wholesale onboarding
• Consumer dosing or clinic kit programs
• Invented certifications or ranking claims
• A substitute for your own import/customer compliance review

Explicit declines: no performance mall, no consumer dosing, no clinic kits (Compliance).

---

RFQ stub (distributor / wholesale)

> Distributor qualification RFQ: company ___; target SKUs ___; Track A trial qty ___; bulk powder interest [yes/no]; destination markets/docs ___; COA with HPLC [yes]; MS [required/not]; prior lot retention process [described]; OEM interest [yes/no]; target first ship window ___.

Submit via Quote Cart. Browse catalog first on Products.

---

Distributors who institutionalize this checklist usually reduce second-PO surprises: fewer missing COAs, fewer assortment conflicts, and clearer bulk vs vial economics before forecasting season.

Related reading

• MOQ and trial kits
• Batch numbers & reorders
• China partner questions
• Glutathione buyer guide
• Distributors hub · Fact Sheet · Quote

---

Next step

Browse Products, open the Distributors hub, review COA Vault, then send a structured RFQ via Quote Cart or place a Track A trial under declared MOQ.

Peptisova partners with B2B distributors on catalog, bulk, and qualified OEM paths only—not gray retail or consumer dosing programs.